In a model of sepsis-associated AKI, polydatin, another activator of NRF2, was found to mitigate the elevation of serum creatinine and BUN levels by significantly increasing the expression of NRF2 and HO-1. This evidence concerns the gene NFE2L2 and acute kidney injury.